Published in Inflammation on April 01, 2011
Pathophysiology of LV Remodeling in Survivors of STEMI: Inflammation, Remote Myocardium, and Prognosis. JACC Cardiovasc Imaging (2015) 1.69
High-throughput 13-parameter immunophenotyping identifies shifts in the circulating T-cell compartment following reperfusion in patients with acute myocardial infarction. PLoS One (2012) 0.87
Impact of white blood cell count on myocardial salvage, infarct size, and clinical outcomes in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a magnetic resonance imaging study. Int J Cardiovasc Imaging (2013) 0.80
Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation. Neth Heart J (2016) 0.77
Elevated mean neutrophil volume represents altered neutrophil composition and reflects damage after myocardial infarction. Basic Res Cardiol (2015) 0.76
Echocardiographic epicardial fat thickness is a predictor for target vessel revascularization in patients with ST-elevation myocardial infarction. Lipids Health Dis (2016) 0.75
Platelet-to-lymphocyte ratio but not neutrophil-to-lymphocyte ratio predicts high on-treatment platelet reactivity in clopidogrel-treated patients with acute coronary syndrome. Indian J Pharmacol (2016) 0.75
Stage-dependent detection of CD14+ and CD16+ cells in the human heart after myocardial infarction. Virchows Arch (2013) 0.75
Universal definition of myocardial infarction. J Am Coll Cardiol (2007) 8.68
The inflammatory response in myocardial infarction. Cardiovasc Res (2002) 7.92
Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction:a possible role for left ventricular remodeling. J Am Coll Cardiol (2002) 3.27
Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J (2004) 3.19
Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med (2001) 2.82
Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy. Circulation (2000) 2.01
Significance of total and differential leucocyte count in patients with acute myocardial infarction treated with primary coronary angioplasty. Eur Heart J (2006) 1.99
Association of peripheral neutrophilia with adverse angiographic outcomes in ST-elevation myocardial infarction. Am J Cardiol (2004) 1.96
Prevention of lymphocyte apoptosis--a potential treatment of sepsis? Clin Infect Dis (2005) 1.58
Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation (2003) 1.45
The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study. J Am Coll Cardiol (2002) 1.28
Uncontrolled immune response in acute myocardial infarction: unraveling the thread. Am Heart J (2008) 0.96
Cytokine profiles and T cell function in acute coronary syndromes. Atherosclerosis (2006) 0.93
Usefulness of a comprehensive cardiovascular magnetic resonance imaging assessment for predicting recovery of left ventricular wall motion in the setting of myocardial stunning. J Am Coll Cardiol (2005) 0.86
Prognostic value of leukocytosis in acute coronary syndromes: the cinderella of the inflammatory markers. Curr Med Chem (2006) 0.85
Evolution of 5 cardiovascular magnetic resonance-derived viability indexes after reperfused myocardial infarction. Am Heart J (2007) 0.81
Post-reperfusion lymphopenia and microvascular obstruction in ST-segment elevation acute myocardial infarction. Rev Esp Cardiol (2009) 0.77
The association of impaired myocardial perfusion and monocytosis with late recovery of left ventricular function following primary percutaneous coronary intervention. Eur Heart J (2006) 0.75
A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet (2002) 3.19
Antigen carbohydrate 125 in heart failure: not just a surrogate for serosal effusions? Int J Cardiol (2010) 2.94
Reversal of rivaroxaban-induced alterations on hemostasis by different coagulation factor concentrates – in vitro studies with steady and circulating human blood. Circ J (2014) 2.49
Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol (2008) 2.26
A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure. J Am Coll Cardiol (2007) 2.15
Effect of opening a new catheterization laboratory on 30-day and 2-year survival rates in myocardial infarction patients. Rev Esp Cardiol (2011) 2.14
Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos). J Am Coll Cardiol (2008) 2.11
Natural course of sleep-disordered breathing after acute myocardial infarction. Eur Respir J (2012) 1.74
Metabolomic profile of human myocardial ischemia by nuclear magnetic resonance spectroscopy of peripheral blood serum: a translational study based on transient coronary occlusion models. J Am Coll Cardiol (2012) 1.70
Prognostic value of a comprehensive cardiac magnetic resonance assessment soon after a first ST-segment elevation myocardial infarction. JACC Cardiovasc Imaging (2009) 1.60
Analysis of chronic lymphotic leukemia transcriptomic profile: differences between molecular subgroups. Leuk Lymphoma (2009) 1.58
The left radial approach in daily practice. A randomized study comparing femoral and right and left radial approaches. Rev Esp Cardiol (2009) 1.57
Association of early repolarization pattern on ECG with risk of cardiac and all-cause mortality: a population-based prospective cohort study (MONICA/KORA). PLoS Med (2010) 1.56
Right ventricular involvement in anterior myocardial infarction: a translational approach. Cardiovasc Res (2010) 1.54
Association of polymorphisms of the apolipoprotein(a) gene with lipoprotein(a) levels and myocardial infarction. Circulation (2003) 1.49
Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes. Cochrane Database Syst Rev (2010) 1.49
Non-ST-elevation acute myocardial infarction with normal coronary arteries: predictors and prognosis. Rev Esp Cardiol (2009) 1.49
Persistent truncus arteriosus type 4 with survival to the age of 54 years. Int J Cardiol (2002) 1.49
CA125 and immunoinflammatory activity in acute heart failure. Int J Cardiol (2010) 1.48
Significance of tilt table testing in patients with suspected arrhythmic syncope and negative electrophysiologic study. J Cardiovasc Electrophysiol (2005) 1.44
[Abnormal myocardial perfusion after infarction in patients with persistent TIMI grade-3 flow. Only an acute phenomenon?]. Rev Esp Cardiol (2007) 1.43
New epicardial mapping electrode with warming/cooling function for experimental electrophysiology studies. Med Eng Phys (2011) 1.42
Dynamics of serum-induced endothelial cell apoptosis in patients with myocardial infarction. Eur J Clin Invest (2013) 1.42
Cardiac magnetic resonance evaluation of edema after ST-elevation acute myocardial infarction. Rev Esp Cardiol (2009) 1.42
A practical approach with outcome for the prognostic assessment of non-ST-segment elevation chest pain and normal troponin. Am J Cardiol (2007) 1.41
[Time-frequency analysis of ventricular fibrillation. An experimental study]. Rev Esp Cardiol (2006) 1.41
Additional diagnostic value of systolic dysfunction induced by dipyridamole stress cardiac magnetic resonance used in detecting coronary artery disease. Rev Esp Cardiol (2009) 1.41
Role of the paclitaxel-eluting stent and tirofiban in patients with ST-elevation myocardial infarction undergoing postfibrinolysis angioplasty: the GRACIA-3 randomized clinical trial. Circ Cardiovasc Interv (2010) 1.40
Increased mortality in patients with diabetes associated with olmesartan for the prevention/delay of microalbuminuria onset: a matter of concern? Rev Esp Cardiol (Engl Ed) (2011) 1.39
[Sex differences in mortality at one-month and at one-year after an acute coronary syndrome]. Med Clin (Barc) (2004) 1.39
Tricuspid Regurgitation and Mortality Risk Across Left Ventricular Systolic Function in Acute Heart Failure. Circ J (2015) 1.39
Annual summary 2010: bibliometric data, activities, and new production of the journal. Rev Esp Cardiol (2010) 1.39
Unplanned redundant publication: a consequence of too many cardiovascular journals? EuroIntervention (2010) 1.39
Effect of invasive treatment on prognosis in non-ST-segment elevation acute coronary syndrome with or without systolic dysfunction. Rev Esp Cardiol (2010) 1.39
[Reperfusion treatment in an acute myocardial infarction in patients older than 75 years. Do we need a randomized controlled trial?]. Rev Esp Cardiol (2005) 1.37
Release of necrosis markers and cardiovascular magnetic resonance-derived microvascular perfusion in reperfused ST-elevation myocardial infarction. Thromb Res (2009) 1.37
Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Hypertension (2005) 1.32
Implantation of single-lead atrioventricular permanent pacemakers guided by electroanatomic navigation without the use of fluoroscopy. Europace (2008) 1.30
Continuous ambulatory peritoneal dialysis as a therapeutic alternative in patients with advanced congestive heart failure. Eur J Heart Fail (2012) 1.25
Prognostic value of dipyridamole stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease. J Am Coll Cardiol (2007) 1.17
Virological and immunological features of active cytomegalovirus infection in nonimmunosuppressed patients in a surgical and trauma intensive care unit. J Med Virol (2010) 1.15
Red blood cell distribution width is longitudinally associated with mortality and anemia in heart failure patients. Circ J (2013) 1.14
Differential prognostic effect of systolic blood pressure on mortality according to left-ventricular function in patients with acute heart failure. Eur J Heart Fail (2010) 1.12
Prognostic impact of sleep disordered breathing and its treatment in heart failure: an observational study. Eur J Heart Fail (2010) 1.10
Worsening Renal Function in Acute Decompensated Heart Failure: The Puzzle is Still Incomplete. JACC Heart Fail (2015) 1.10
[Reliability of cardiac magnetic resonance imaging indicators of myocardial viability for predicting the recovery of systolic function after a first acute myocardial infarction with a patent culprit artery]. Rev Esp Cardiol (2004) 1.08
Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats. Cardiovasc Pathol (2004) 1.06
Effects of pitavastin in Japanese patients with chronic heart failure. Circ J (2013) 1.06
Letter by Nunez et al regarding article, "Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction". Circ Heart Fail (2013) 1.06
Immediate Invasive Strategy for Patients With Both New Ischemic Electrocardiographic Changes and Troponin Elevation. JACC Cardiovasc Interv (2016) 1.05
RANTES gene polymorphisms predict all-cause and cardiac mortality in type 2 diabetes mellitus hemodialysis patients. Atherosclerosis (2005) 1.02
Variable phenotypes of bicuspid aortic valve disease: classification by cardiovascular magnetic resonance. Heart (2010) 1.02
Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate antigen 125 following a hospitalization for acute heart failure. Eur J Heart Fail (2012) 1.01
Peripheral T-cell lymphoma associated consecutively with hemophagocytic lymphohistiocytosis and hypereosinophilic syndrome. Eur J Haematol (2003) 1.00
Nocturnal continuous positive airway pressure improves ventilatory efficiency during exercise in patients with chronic heart failure. Chest (2005) 1.00
Dynamics of cytomegalovirus (CMV) plasma DNAemia in initial and recurrent episodes of active CMV infection in the allogeneic stem cell transplantation setting: implications for designing preemptive antiviral therapy strategies. Biol Blood Marrow Transplant (2011) 1.00
One-week and 6-month cardiovascular magnetic resonance outcome of the pharmacoinvasive strategy and primary angioplasty for the reperfusion of ST-segment elevation myocardial infarction. Rev Esp Cardiol (2011) 0.99
Gender-specific differences of cardiac remodeling in subjects with left ventricular dysfunction: a population-based study. Cardiovasc Res (2002) 0.98
Uncontrolled immune response in acute myocardial infarction: unraveling the thread. Am Heart J (2008) 0.96